PatternsRadar
Sign in

BAFNAPHBafna Pharmaceuticals Limited

NSE
Full chart
394.00INR+7.70 (+1.99%)Close · 6 Oct 2026
11 Aug 2026Last results
—Sector
—Industry
₹932 CrMarket cap
119.7P/E (TTM)
100.0%Delivery

Filings & corporate actions

26 results filed
CSV
Next results · Q2 FY27
Expected 10 Nov 2026 – 12 Nov 2026
Estimate: filed 41–43 days after quarter end, last 5 times
2026
  • 11 AugresultsResults · Q1 FY27 · standalone-2.0%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026+1.4%NSE
  • 29 MayresultsResults · Q4 FY26 · standalone+5.0%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026+2.2%NSE
  • 11 FebresultsResults · Q3 FY26 · standalone-3.5%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025-4.3%NSE

Reaction to results · all yearsrose on day 0 in 16 of 26 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2711 Aug 2026-2.0%-11.4%+10.2%0.1×
Q4 FY2629 May 2026+5.0%+47.1%+62.7%3.6×
Q3 FY2611 Feb 2026-3.5%-9.6%-22.7%1.3×
Q2 FY2611 Nov 2025-2.0%-11.4%-27.3%6.9×
Q1 FY2612 Aug 2025+10.0%+10.0%+29.5%15.3×
Q4 FY2526 May 2025+2.2%0.0%+3.7%1.0×
Q3 FY257 Feb 2025+1.2%-6.3%+2.0%0.9×
Q2 FY2512 Nov 2024-1.8%-3.2%-1.8%1.4×
Q1 FY2514 Aug 2024+2.7%-3.8%-7.3%1.5×
Q4 FY2430 May 2024-5.0%-7.5%-4.4%0.1×
Q3 FY2413 Feb 2024+0.5%-3.5%-12.4%0.5×
Q2 FY2410 Nov 2023+3.0%+6.3%+23.2%0.2×
Q1 FY2412 Aug 2023+5.0%+9.7%-4.9%0.3×
Q4 FY2327 May 2023+5.0%+33.8%-3.0%0.8×
Q3 FY239 Feb 2023-2.2%-4.4%-3.3%2.0×
Q2 FY2312 Nov 2022+2.0%-1.5%+1.3%0.8×
Q1 FY2312 Aug 2022+5.0%+6.5%+1.9%12.3×
Q4 FY2227 May 2022+3.3%+1.3%-0.7%0.3×
Q3 FY2211 Feb 2022-2.6%-14.5%-23.4%0.9×
Q2 FY2212 Nov 2021+5.0%-2.6%+7.3%3.2×
Q1 FY225 Aug 2021-2.2%-4.2%-14.7%0.3×
Q4 FY2126 Jun 2021+1.0%-2.5%+10.6%2.1×
Q3 FY2112 Feb 2021+5.0%+9.7%+32.0%0.8×
Q2 FY2112 Nov 2020+5.0%-8.1%+12.9%0.6×
Q1 FY2110 Sept 20200.0%+27.0%+161.3%0.1×
Q4 FY2025 Jun 20200.0%0.0%+61.4%0.3×
Average+1.5%+2.2%+11.3%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q4 FY20

CSV
Revenue YoY-23.2%
Profit YoY-97.8%
Interest cost YoY+23.7%
Revenue QoQ-37.1%
Profit QoQ-97.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue-0.4%+0.5%+15.3%+13.5%——
Profit+433.7%-21.9%+15.2%+5.0%——

Key data

CSV
Open394.00
Day range393.00 – 394.00
52-week range94.77 – 394.00
From 52w high0.0%
RSI (14)87.2
ATR (14)7.25
Volume480
Avg volume (20D)4.3K
Rel volume0.11×
Volatility (1Y)50.3%
Turnover₹1.9L
SMA 50 / 200296.24 / 182.36

Delivery percentage

Latest · 6 Oct 2026100.0%
20-day avg100.0%
1-year avg95.5%
Percentile (own history)100th
Range0.9–100.0%
Sessions1,461

Over the last 20 sessions BAFNAPH settled 100.0% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 95.5%, so recent sessions are running 4.5 points higher than usual. That is the highest reading in the 1,461 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Performance returns

CSV
1D1W1M3M6M1Y
Price+1.99%+10.35%+30.53%+89.52%+253.93%+123.44%

Valuation

CSV
Market cap₹932 Cr
P/E (TTM)119.7
EPS (TTM)3.29
Shares outstanding23.65L
Listed—

Ownership

CSV
Promoter75.00%
Promoter Δ QoQ0.00 pp
Public25.00%
FII9.34%
DII0.00%
Pledged0.00%

Quarterly results · consolidated

CSV
Q4 FY20
Revenue (₹ Cr)13.1
YoY chg—
Net profit (₹ Cr)0.3
YoY chg—
Net margin2.4%
EPS0.20

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 75.00% · public 25.00%
30 Sept 2021: promoter 90.40%31 Dec 2021: promoter 90.42%31 Mar 2022: promoter 90.42%30 Jun 2022: promoter 90.12%30 Sept 2022: promoter 90.00%31 Dec 2022: promoter 90.02%31 Mar 2023: promoter 90.00%30 Jun 2023: promoter 90.00%30 Sept 2023: promoter 88.74%31 Dec 2023: promoter 88.43%31 Mar 2024: promoter 88.30%30 Jun 2024: promoter 88.30%30 Sept 2024: promoter 88.30%31 Dec 2024: promoter 88.30%31 Mar 2025: promoter 75.00%30 Jun 2025: promoter 75.00%30 Sept 2025: promoter 75.00%31 Dec 2025: promoter 75.00%31 Mar 2026: promoter 75.00%30 Jun 2026: promoter 75.00%
2021-092026-06
  • Promoter
  • Public and others
Promoter
75.00%
Public
25.00%
Promoter change
0.00 pp
Filed
20 Jul 2026
FII
9.34%
DII
0.00%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q4 FY20A
Revenue from operations13.1
Other income(0.7)
Total income12.5
Total expenses9.4
└ Finance costs0.0
└ Depreciation0.5
Profit before tax2.2
Tax expense1.6
Net profit0.3
EPS0.20
Net margin2.42%
PBT margin16.62%
Tax rate72.30%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 25 Jun 2020.

1 quarter on file; a year-on-year comparison needs five.

BAFNAPH at a glance

  • BAFNAPH closed at ₹394 on 6 Oct 2026, +1.99% on the day, +123.4% over one year, at its 52-week high of ₹394.
  • Delivery was 100.0% of traded quantity on 6 Oct 2026, the 100th percentile of its own 1,461 sessions with a reading (20-session average 100.0%, 1-year average 95.5%).
  • Market capitalisation is ₹932 crore at a trailing P/E of 119.7 (trailing EPS ₹3.29).
  • Q4 FY20 results (consolidated, filed 25 Jun 2020): revenue ₹13 crore, net profit ₹0 crore; the price moved 0.0% on the first session after.
  • Promoters held 75.00% at 30 Jun 2026, unchanged on the previous filing.
  • Q2 FY27 results are expected between 10 Nov 2026 and 12 Nov 2026, going by past filing dates — an estimate, not an announcement.